Wikidata:Database reports/Constraint violations/P3356

• Summary
• List of properties
• Property proposal
• Popular properties
• Special:ConstraintReport

Constraint violations report for positive diagnostic predictor for (Discussion, uses, items, changes, related properties): the presence of the genetic variant helps to diagnose the presence of disease, used as inclusion criteria
Data time stamp: 16 February 2024, 11:02 (UTC) — Items processed: 132
The report is generated based on the settings on Property:P3356#P2302.
Updates overwrite this page. Some may already be fixed since the last update: check RecentChangesLinked.
When incremental dumps and the bot work as planned, items fixed before 07:00 UTC disappear in the next update. The report is not updated if only the item count changes.
The report can include false positives. There is no need to "fix" them.

"Scope" violations

Violations count: 0

"Value type disease (Q12136)" violations

Violations count: 0

Types statistics

Accepted	Type	Usage
Yes	disease (Q12136)	72
Yes	precursor B lymphoblastic lymphoma/leukemia (Q18557465)	33
Yes	myeloid leukemia (Q11688946)	23
Yes	acute leukemia (Q976388)	20
Yes	rare disease (Q929833)	18
Yes	glioma (Q1365309)	14
Yes	juvenile astrocytoma (Q18555282)	8
Yes	B-cell lymphoma (Q4833719)	7
Yes	synovium cancer (Q18555170)	6
Yes	thyroid carcinoma (Q18556131)	5
Yes	brain cancer (Q9303627)	5
Yes	connective tissue benign neoplasm (Q18553680)	5
Yes	chronic leukemia (Q5113979)	5
Yes	sex cord-gonadal stromal tumor (Q5474322)	5
Yes	malformation syndrome with hamartosis (Q55789095)	4
Yes	mesenchymal cell neoplasm (Q18555386)	4
Yes	tumor of hematopoietic and lymphoid tissues (Q2509220)	4
Yes	connective tissue neoplasm (Q3542012)	4
Yes	hemangioblastoma (Q460937)	4
Yes	multiple polyglandular tumor (Q55785235)	4
Yes	genetic central nervous system and retinal vascular disease (Q55785839)	4
Yes	inherited renal tumor (Q55785849)	4
Yes	hereditary eye tumor (Q55785853)	4
Yes	syndromic developmental defect of the eye (Q55785336)	4
Yes	inherited nervous system cancer-predisposing syndrome (Q55786407)	4
Yes	thyroid gland disease (Q6673122)	4
Yes	syndromic glaucoma (Q55789219)	4
Yes	aggressive B-cell non-Hodgkin lymphoma (Q55787212)	4
Yes	central nervous system and retinal vascular disease (Q55788489)	4
Yes	head and neck disease (Q55789477)	4
Yes	catecholamine-producing tumor (Q55788491)	4
Yes	developmental defect during embryogenesis (Q55788864)	4
Yes	familial cystic renal disease (Q55788849)	4
Yes	chondrosarcoma (Q1076087)	3
Yes	small cell sarcoma (Q18555287)	3
Yes	testicular sex cord-stromal neoplasm (Q18556466)	3
Yes	thoracic cancer (Q18556617)	3
Yes	hematopoietic system disease (Q1963588)	3
Yes	sarcoma (Q223911)	3
Yes	breast neoplasm (Q23929670)	3
Yes	carcinoma (Q33525)	3
Yes	adenocarcinoma (Q356033)	3
Yes	breast disease (Q4959796)	3
Yes	Ewing sarcoma (Q1138580)	3
Yes	organ system cancer (Q18553400)	3
Yes	endocrine gland cancer (Q18554878)	3
Yes	thyroid neoplasm (Q13632630)	3
Yes	fibromatosis (Q1410851)	3
Yes	lung neoplasm (Q15124212)	2
Yes	skin cancer (Q192102)	2
Yes	lymphoblastic leukemia (Q18553852)	2
Yes	lung disease (Q3392853)	2
Yes	cell type cancer (Q18553402)	2
Yes	lung cancer (Q47912)	2
Yes	liposarcoma (Q1827425)	2
Yes	childhood cancer (Q5097977)	2
Yes	Ewing family of tumor (Q5419064)	2
Yes	follicular thyroid cancer (Q5464665)	2
Yes	B-cell non-Hodgkin lymphoma (Q55785695)	2
Yes	myxoid tumor (Q16666910)	2
Yes	papillary carcinoma (Q18555294)	2
Yes	embryonal tumor of neuroepithelial tissue (Q55786381)	2
Yes	medulloblastoma (Q1333608)	2
Yes	cancer (Q12078)	2
Yes	differentiated thyroid carcinoma (Q56013722)	2
Yes	bone sarcoma (Q56014469)	2
Yes	hepatocellular carcinoma (Q1148337)	2
Yes	respiratory system cancer (Q7315926)	2
Yes	T-cell leukemia (Q7667895)	2
Yes	chronic lymphocytic leukemia (Q1088156)	2
Yes	B-cell acute lymphoblastic leukemia (Q102293395)	2
Yes	rhabdomyosarcoma (Q1898141)	2
Yes	central nervous system cancer (Q18556002)	2
Yes	bile duct adenocarcinoma (Q18556530)	2
Yes	cerebrum cancer (Q18556019)	2
Yes	precursor lymphoblastic lymphoma/leukemia (Q18556893)	2
Yes	infratentorial cancer (Q18556448)	2
Yes	childhood infratentorial neoplasm (Q18556231)	2
Yes	bone cancer (Q18554919)	2
Yes	inherited digestive tract tumor (Q55786847)	1
Yes	bone neoplasm (Q1328805)	1
Yes	skin tumor or hamartoma (Q55788604)	1
Yes	dermis disorder (Q55788597)	1
Yes	renal carcinoma (Q18556333)	1
Yes	fibrosarcoma (Q1362453)	1
Yes	mesenchymal tumor of small intestine (Q55788134)	1
Yes	rare tumor (Q55789070)	1
Yes	inherited soft tissue tumor (Q55786846)	1
Yes	histiocytoid hemangioma (Q18556461)	1
Yes	reproductive organ cancer (Q18554942)	1
Yes	genetic syndromic intellectual disability (Q55785866)	1
Yes	thrombogavitis (Q1542410)	1
Yes	carbohydrate metabolic disorder (Q6013981)	1
Yes	skin sarcoma (Q18555161)	1
Yes	myeloproliferative neoplasm (Q18555039)	1
Yes	spindle cell/sclerosing rhabdomyosarcoma (Q92468116)	1
Yes	vascular tissue neoplasm (Q7916470)	1
Yes	lung carcinoma (Q18556110)	1
Yes	chronic myeloid leukemia (Q729735)	1
Yes	medullary carcinoma (Q6807316)	1
Yes	lipomatous cancer (Q18556123)	1
Yes	sexually transmitted infection (Q12198)	1
Yes	female reproductive system neoplasm (Q56014489)	1
Yes	giant cell tumor (Q18554961)	1
Yes	low grade glioma (Q55789758)	1
Yes	nerve sheath neoplasms (Q11590740)	1
Yes	renal cell carcinoma (Q1164529)	1
Yes	clear cell carcinoma (Q18556242)	1
Yes	acquired neutropenia (Q55785744)	1
Yes	leukemia (Q29496)	1
Yes	epithelioid hemangioendothelioma (Q1887340)	1
Yes	congenital disorder of glycosylation type I (Q18553313)	1
Yes	malignant hemangioma (Q39656442)	1
Yes	undifferentiated carcinoma (Q3658394)	1
Yes	hematologic cancer (Q18975047)	1
Yes	spindle cell cancer (Q18975358)	1
Yes	Human T-lymphotropic virus 1 infectious disease (Q18975385)	1
Yes	mature T-cell and NK-cell lymphoma (Q18553445)	1
Yes	skin melanoma (Q18558032)	1
Yes	acute myeloid leukemia (Q264118)	1
Yes	benign neoplasms by histologic type (Q18553645)	1
Yes	bone benign neoplasm (Q18553654)	1
Yes	myeloid neoplasm (Q18553734)	1
Yes	genetic disease (Q200779)	1
Yes	malignant peripheral nerve neoplasm (Q18975993)	1
Yes	myeloproliferative disorders (Q1898104)	1
Yes	fibrolamellar hepatocellular carcinoma (Q5446468)	1
Yes	myelodysplastic/myeloproliferative neoplasm (Q18556570)	1
Yes	myeloid neoplasms associated with eosinophilia and abnormality of PDGFRA, PDGFRB or FGFR1 (Q55785647)	1
Yes	rare genetic intestinal disease (Q55785596)	1
Yes	vascular cancer (Q1683689)	1
Yes	Stromal tumor (Q16869243)	1
Yes	bilineal acute myeloid leukemia (Q55783213)	1
Yes	gastrointestinal system cancer (Q5526839)	1
Yes	ovarian cancer (Q172341)	1
Yes	bone marrow disease (Q18556569)	1
Yes	female reproductive system disease (Q5442760)	1
Yes	embryonal rhabdomyosarcoma (Q5370233)	1
Yes	astrocytoma (Q177755)	1
Yes	ovarian small cell carcinoma (Q18557163)	1
Yes	bladder cancer (Q504775)	1
Yes	prostate cancer (Q181257)	1
Yes	B-cell leukemia (Q4833721)	1

"Type sequence variant (Q15304597)" violations

Violations count: 24

• NPM1 W288FS (Q28381458): Frameshift Elongation (Q28381989)
• FLT3 TKD MUTATION (Q28381821): Nonsynonymous Variant (Q27905684)
• TERT Promoter Mutation (Q28382152): Regulatory Region Variant (Q28381988)
• TERT C228T (Q28382166): Regulatory Region Variant (Q28381988)
• FOXP1 AMPLIFICATION (Q28444941): Transcript Amplification (Q27907091)
• REL AMPLIFICATION (Q28444942): Transcript Amplification (Q27907091)
• KIT rs17084733 (Q28531492): 3 Prime UTR Variant (Q28419124)
• ACVR1 Gain-of-Function (Q44847200):
• DICER1 D1709N (Q56240966):
• VHL 3p26.3-25.3 11Mb del (Q56241025):
• VHL c.208G > A (Q56241026):
• CALR Mutation (Q56241034):
• PRKCB D427N (Q56615783):
• H3-3B K36M (Q76176922):
• H3-3A G34W (Q76176939):
• H3-3A K27M (Q88411882):
• FGFR1 Internal Duplication (Q88412210):
• CTNNB1 exon 3 mutations (Q96008265):
• ATRX Mutation (Q99542859):
• CTNNB1 Exon 3 Mutation (Q104539495):
• SMARCB1 LOSS (Q104539535):
• ACVR1 MUTATION (Q110650112):
• ACVR1 R206H (Q110650758):
• ACVR1 G356D (Q110650775):

Types statistics

Accepted	Type	Usage
Yes	transcript fusion (Q28419128)	61
Yes	missense mutation (Q2656896)	27
Yes	Protein Altering Variant (Q27907087)	9
Yes	Loss Of Function Variant (Q27907094)	3
Yes	sequence variant (Q15304597)	3
Yes	Gain Of Function Variant (Q28371786)	2
No	Regulatory Region Variant (Q28381988)	2
Yes	Stop Gained (Q28371788)	2
No	Transcript Amplification (Q27907091)	2
Yes	Frameshift Truncation (Q28371705)	1
Yes	Inframe Insertion (Q27908066)	1
Yes	Coding Sequence Variant (Q28371787)	1
Yes	exon variant (Q27908063)	1
Yes	gene variant (Q28381983)	1
No	Frameshift Elongation (Q28381989)	1
No	3 Prime UTR Variant (Q28419124)	1
No	Nonsynonymous Variant (Q27905684)	1
Yes	single-nucleotide polymorphism (Q501128)	1

"Entity types" violations

Violations count: 0